Previous studies have demonstrated the importance of FGFR2 for cell migration, invasion, growth and cancer progression in CRC (57), with gene amplification being reported in primary CRC (58), and expression being associated with poor survival (59). Here, FGFR2 is linked to colorectal carcinoma.